BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23406751)

  • 41. CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes.
    Kajita J; Kuwabara T; Kobayashi H; Kobayashi S
    Drug Metab Dispos; 2000 Sep; 28(9):1121-7. PubMed ID: 10950859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytochrome P450 expression and testosterone metabolism in the liver of deer.
    Sivapathasundaram S; Magnisali P; Coldham NG; Howells LC; Sauer MJ; Ioannides C
    Toxicology; 2003 May; 187(1):49-65. PubMed ID: 12679052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the effects of hydrophilic organic solvents on CYP3A-mediated drug-drug interaction in vitro.
    Iwase M; Kurata N; Ehana R; Nishimura Y; Masamoto T; Yasuhara H
    Hum Exp Toxicol; 2006 Dec; 25(12):715-21. PubMed ID: 17286149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Metabolic Activities Catalyzed by Human Cytochrome P450 (CYP) 2D6 and CYP3A Subfamily Members and Effect of Various Compounds, Including Endogenous Steroid Hormones, on These Activities].
    Niwa T
    Yakugaku Zasshi; 2024; 144(2):197-202. PubMed ID: 38296497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama).
    Skálová L; Szotáková B; Machala M; Neca J; Soucek P; Havlasová J; Wsól V; Krídová L; Kvasnicková E; Lamka J
    Chem Biol Interact; 2001 Aug; 137(2):155-67. PubMed ID: 11551531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thin-layer chromatography analysis of human CYP3A-catalyzed testosterone 6beta-hydroxylation.
    Waxman DJ; Chang TK
    Methods Mol Biol; 2006; 320():133-41. PubMed ID: 16719384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Posttranslational elevation of cytochrome P450 3A levels and activity by dimethyl sulfoxide.
    Zangar RC; Novak RF
    Arch Biochem Biophys; 1998 May; 353(1):1-9. PubMed ID: 9578594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human.
    Emoto C; Yamazaki H; Iketaki H; Yamasaki S; Satoh T; Shimizu R; Suzuki S; Shimada N; Nakajima M; Yokoi T
    Xenobiotica; 2001 May; 31(5):265-75. PubMed ID: 11491388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the effect of five phenothiazines on hepatic CYP isoenzymes in rats.
    Tateishi T; Kumai T; Watanabe M; Tanaka M; Kobayashi S
    Pharmacol Toxicol; 1999 Nov; 85(5):252-6. PubMed ID: 10608490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes.
    Chiba M; Nishime JA; Chen IW; Vastag KJ; Sahly YS; Kim BM; Dorsey BD; Vacca JP; Lin JH
    Biochem Pharmacol; 1998 Jul; 56(2):223-30. PubMed ID: 9698076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential of lansoprazole as a novel probe for cytochrome P450 3A activity by measuring lansoprazole sulfone in human liver microsomes.
    Yanagida Y; Watanabe M; Takeba Y; Kumai T; Matsumoto N; Hayashi M; Suzuki S; Kinoshita Y; Kobayashi S
    Biol Pharm Bull; 2009 Aug; 32(8):1422-6. PubMed ID: 19652384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversible and time-dependent inhibition of the hepatic cytochrome P450 steroidal hydroxylases by the proestrogenic pesticide methoxychlor in rat and human.
    Li HC; Mani C; Kupfer D
    J Biochem Toxicol; 1993 Dec; 8(4):195-206. PubMed ID: 8114062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of the expression on constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil.
    Afsar A; Lee C; Riddick DS
    Can J Physiol Pharmacol; 1996 Feb; 74(2):150-6. PubMed ID: 8723027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting the contribution of rat cytochrome P-450 3A1, 3A2 and human cytochrome P-450 3A4, 3A5 to territrem a 4beta-C hydroxylation using the relative activity factor.
    Lin YH; Peng FC
    J Toxicol Environ Health A; 2008; 71(21):1407-14. PubMed ID: 18800290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of pyrazole and dexamethasone administration on cytochrome P450 2E1 and 3A isoforms in rat liver and kidney: lack of specificity of p-nitrophenol as a substrate of P450 2E1.
    Zerilli A; Lucas D; Dreano Y; Picart D; Berthou F
    Alcohol Clin Exp Res; 1998 May; 22(3):652-7. PubMed ID: 9622446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice.
    Bromek E; Danek PJ; Wójcikowski J; Basińska-Ziobroń A; Pukło R; Solich J; Dziedzicka-Wasylewska M; Daniel WA
    Pharmacol Rep; 2022 Oct; 74(5):1107-1114. PubMed ID: 36018449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The combination of chemical and antibody inhibitors for superior P450 3A inhibition in reaction phenotyping studies.
    Rock DA; Foti RS; Pearson JT
    Drug Metab Dispos; 2008 Dec; 36(12):2410-3. PubMed ID: 18765682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats.
    Kanazu T; Yamaguchi Y; Okamura N; Baba T; Koike M
    Xenobiotica; 2004 May; 34(5):403-13. PubMed ID: 15370957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of testosterone and 6beta-hydroxytestosterone by gas chromatography-selected ion monitoring-mass spectrometry for the characterization of cytochrome p450 3A activity.
    Testino SA; Ozarowski J; Thurston AW; Arrendale RF; Patonay G
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):73-81. PubMed ID: 10574192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.